Beijing Tongrentang Co., Ltd (SHA:600085)
China · Delayed Price · Currency is CNY 31.53
+0.07 (0.22%)
At close: Feb 6, 2026
Beijing Tongrentang Revenue
Beijing Tongrentang had revenue of 3.54B CNY in the quarter ending September 30, 2025, a decrease of -12.76%. This brings the company's revenue in the last twelve months to 18.09B, up 0.70% year-over-year. In the year 2024, Beijing Tongrentang had annual revenue of 18.60B with 4.12% growth.
Revenue (ttm)
18.09B
Revenue Growth
+0.70%
P/S Ratio
2.39
Revenue / Employee
1.01M
Employees
17,883
Market Cap
43.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.60B | 736.39M | 4.12% |
| Dec 31, 2023 | 17.86B | 2.49B | 16.19% |
| Dec 31, 2022 | 15.37B | 769.32M | 5.27% |
| Dec 31, 2021 | 14.60B | 1.78B | 13.86% |
| Dec 31, 2020 | 12.83B | -451.24M | -3.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| China Resources Sanjiu Medical & Pharmaceutical | 29.86B |
| Humanwell Healthcare (Group) | 24.18B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Livzon Pharmaceutical Group | 11.85B |
| Dong-E-E-Jiao | 6.12B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |